A practical route through regulatory uncertainty in clinical...

Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.

The reasoning problem

In R&D, decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.

European launch: Manufacturing as cornerstone for success

In Europe, manufacturing may not make headlines in pharma partnering, but it’s one of the foundations on which strong partnerships must be built.

Patient population first: the strategy behind country decisi...

CAMP4 on a new class of ASO in gene under expression

CAMP4 Therapeutics CFO Kelly Gold discusses developments in antisense oligonucleotides and CAMP4’s CMP-002 study

Drug discovery has a human biology problem

The current opportunity lies in optimising existing discovery methodologies by generating more predictive, reproducible human data.